IPO

With a successful $191M IPO, Alamar Biosciences is set to revolutionize diagnostics with its ultra-sensitive proteomics platforms.

Manycore Tech becomes the world's first listed spatial intelligence firm, its blockbuster HKEX debut signaling a new frontier for AI and physical worlds.

On World Hemophilia Day, experts reveal over 75% of people with bleeding disorders are undiagnosed, facing a life of pain without access to basic care.

San Jose-based Metafoodx has launched Catering Mode, an AI tool promising to end guesswork in event foodservice, slash waste, and boost profits.

With a $10M offering led by its first customer, HeartBeam is set to commercialize its revolutionary 3D ECG system for remote heart health.

Bank First reports strong Q1 earnings and a 22% dividend hike, fueled by its Centre acquisition. But rising nonperforming assets show integration challenges.

AI cloud specialist CoreWeave raises another $1 billion in high-yield debt, doubling down on its aggressive expansion to meet insatiable AI demand.

Madison Air Solutions (MAIR) surged nearly 19% in its public debut, raising $2.23 billion in the largest U.S. industrial IPO since 1999.

Celebrating 100 years, Minneapolis-based Graco evolved from a simple invention to a $2B global force whose unseen technologies power our daily lives.

Deep-tech firm AHOY surpasses $100M ARR with its "Real-World AI," now seeking major funding to expand its sovereign AI for critical infrastructure.

Biopharma veteran Glenn Gormley joins Aktis's board, bringing deep ADC expertise to guide the company's next-gen radiopharmaceutical pipeline.

Purdue President Mung Chiang will chair FESI, a key nonprofit tasked with turning U.S. lab breakthroughs into market-ready energy technologies.

As social trading reshapes retail investment, FX Junction earns a top-three ranking. But what does this mean for investors in a high-risk, high-reward era?

Amid rising metal prices, Smooth Rock Ventures restarts exploration at a historic Nevada mine with high-grade nickel, gold, and copper potential.

CirTran reports a 141% revenue jump and narrowing losses, but a closer look reveals one-time gains and significant underlying financial risks.

With a massively oversubscribed €600M hybrid note offering, plant-based leader Roquette secures major funding and a huge vote of investor confidence.

With founder Frédéric Mascha as Executive Chairman and new CEO Renaud Sermondade, Juvisé Pharmaceuticals is poised for major M&A-fueled global expansion.

With revenue up 41% and cash flow soaring 79%, Flow Capital's 10th straight quarter of growth highlights the rising appeal of non-dilutive financing.

Southern First Bancshares priced a new stock offering to fund expansion, a move analysts see as a strategic play balancing long-term growth with shareholder dilution.

Despite major cost cuts and growth in key divisions, DSS, Inc. struggles to convince Wall Street. Can a biotech spin-off finally unlock its true value?